Literature DB >> 15022021

Micrometastases of solitary hepatocellular carcinoma and appropriate resection margin.

Ming Shi1, Chang-Qing Zhang, Ya-Qi Zhang, Xiao-Man Liang, Jin-Qing Li.   

Abstract

We studied the pattern of intrahepatic micrometastases using large pathologic sections on liver resection specimens with ample resection margins from 113 patients with a solitary hepatocellular carcinoma (HCC). The liver tissues around the HCC were divided into proximal and distal areas according to the direction of the portal vein flow. These areas were further divided into zones based on fixed criteria. Altogether, 273 micrometastases were identified, including 254 (93.0%) intravascular micrometastases and 19 (7.0%) tumor satellite micronodules. The distance of spread of these micrometastases ranged from 0.05 to 6.10 cm. The number of micrometastases was less in the proximal area than in the distal area. In addition, the farther the distance away from the primary tumor, the fewer micrometastases there were. Micrometastases extended beyond the 2 cm margin in only nine (8.0%) patients. In conclusion, micrometastases could spread via invasion of portal vein branches at an early stage even when the tumor was solitary and small. Anatomic segment resection is preferred for patients with a solitary HCC. Nonanatomic resection may be used as an alternative in patients with impaired liver function, but adequate resection margins should be achieved. For HCCs < or = 3 cm, a proximal resection margin and a distal margin of 1.0 cm are recommended. For HCCs > 3 cm, a 1.0 proximal resection margin and a 2.0 cm distal margin are recommended.

Entities:  

Mesh:

Year:  2004        PMID: 15022021     DOI: 10.1007/s00268-003-7308-x

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  33 in total

1.  [Micrometastasis distribution in liver tissue surrounding hepatocellular carcinoma].

Authors:  Ming Shi; Changqing Zhang; Kaitao Feng; Yaqi Zhang; Minshan Chen; Rongping Guo; Xiaojun Lin; Jinqing Li
Journal:  Zhonghua Zhong Liu Za Zhi       Date:  2002-05

2.  Adjuvant intra-arterial iodine-131-labelled lipiodol for resectable hepatocellular carcinoma: a prospective randomised trial.

Authors:  W Y Lau; T W Leung; S K Ho; M Chan; D Machin; J Lau; A T Chan; W Yeo; T S Mok; S C Yu; N W Leung; P J Johnson
Journal:  Lancet       Date:  1999-03-06       Impact factor: 79.321

3.  Surgical margin and recurrence after resection of hepatocellular carcinoma in patients with cirrhosis. Further evaluation of limited hepatic resection.

Authors:  Y Yoshida; T Kanematsu; T Matsumata; K Takenaka; K Sugimachi
Journal:  Ann Surg       Date:  1989-03       Impact factor: 12.969

4.  Significance of resection margin in hepatectomy for hepatocellular carcinoma: A critical reappraisal.

Authors:  R T Poon; S T Fan; I O Ng; J Wong
Journal:  Ann Surg       Date:  2000-04       Impact factor: 12.969

5.  Postoperative recurrence of hepatocellular carcinoma.

Authors:  T Nagao; S Inoue; F Yoshimi; M Sodeyama; Y Omori; T Mizuta; N Kawano; Y Morioka
Journal:  Ann Surg       Date:  1990-01       Impact factor: 12.969

6.  Clinical significance of microscopic tumor venous invasion in patients with resectable hepatocellular carcinoma.

Authors:  T J Tsai; G Y Chau; W Y Lui; S H Tsay; K L King; C C Loong; C Y Hsia; C W Wu
Journal:  Surgery       Date:  2000-06       Impact factor: 3.982

7.  Intrahepatic metastases in hepatocellular carcinoma: evidence for spread via the portal vein as an efferent vessel.

Authors:  A Toyosaka; E Okamoto; M Mitsunobu; T Oriyama; N Nakao; K Miura
Journal:  Am J Gastroenterol       Date:  1996-08       Impact factor: 10.864

8.  Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis.

Authors:  S Jonas; W O Bechstein; T Steinmüller; M Herrmann; C Radke; T Berg; U Settmacher; P Neuhaus
Journal:  Hepatology       Date:  2001-05       Impact factor: 17.425

9.  Early hepatocellular carcinoma as an entity with a high rate of surgical cure.

Authors:  T Takayama; M Makuuchi; S Hirohashi; M Sakamoto; J Yamamoto; K Shimada; T Kosuge; S Okada; K Takayasu; S Yamasaki
Journal:  Hepatology       Date:  1998-11       Impact factor: 17.425

10.  Clinicopathological criteria for multicentricity of hepatocellular carcinoma and risk factors for such carcinogenesis.

Authors:  S Kubo; S Nishiguchi; K Hirohashi; T Shuto; T Kuroki; S Minamitani; T Ikebe; T Yamamoto; K Wakasa; H Kinoshita
Journal:  Jpn J Cancer Res       Date:  1998-04
View more
  56 in total

1.  Microvascular invasion in hepatocellular carcinoma.

Authors:  Emre Ünal; İlkay Sedakat İdilman; Deniz Akata; Mustafa Nasuh Özmen; Muşturay Karçaaltıncaba
Journal:  Diagn Interv Radiol       Date:  2016 Mar-Apr       Impact factor: 2.630

2.  Radiofrequency ablation versus surgical resection for the treatment of hepatocellular carcinoma conforming to the Milan criteria: systemic review and meta-analysis.

Authors:  Hui-Ming Yi; Wei Zhang; Xi Ai; Kai-Yan Li; You-Bin Deng
Journal:  Int J Clin Exp Med       Date:  2014-10-15

3.  Assessment of the effect of the Aquamantys® system on local recurrence after hepatectomy for hepatocellular carcinoma through propensity score matching.

Authors:  M H Sui; H G Wang; M Y Chen; T Wan; B Y Hu; Y W Pan; H Li; H Y Cai; C Cui; S C Lu
Journal:  Clin Transl Oncol       Date:  2019-03-25       Impact factor: 3.405

4.  The role of radiofrequency ablation to liver transection surface in patients with close tumor margin of HCC during hepatectomy-a case matched study.

Authors:  C Nicholas Kotewall; Tan To Cheung; Wong Hoi She; Ka Wing Ma; Simon Hing Ying Tsang; Jeff Wing Chiu Dai; Albert Chi Yan Chan; Kenneth Siu Ho Chok; Chung Mau Lo
Journal:  Transl Gastroenterol Hepatol       Date:  2017-04-28

Review 5.  Radiofrequency ablation-combined multimodel therapies for hepatocellular carcinoma: Current status.

Authors:  Lumin Chen; Jihong Sun; Xiaoming Yang
Journal:  Cancer Lett       Date:  2015-10-22       Impact factor: 8.679

6.  Radiofrequency ablation or microwave ablation combined with transcatheter arterial chemoembolization in treatment of hepatocellular carcinoma by comparing with radiofrequency ablation alone.

Authors:  Yongxiang Yi; Yufeng Zhang; Qiang Wei; Liang Zhao; Jianbo Han; Yan Song; Ying Ding; Guilan Lu; Junmao Liu; Huaiying Ding; Feng Dai; Xiaojun Tang
Journal:  Chin J Cancer Res       Date:  2014-02       Impact factor: 5.087

7.  Combination of radiofrequency ablation with transarterial chemoembolization for hepatocellular carcinoma: an up-to-date meta-analysis.

Authors:  Zhenyin Liu; Fei Gao; Guang Yang; Sristi Singh; Mingjian Lu; Tao Zhang; Zhihui Zhong; Fujun Zhang; Rijie Tang
Journal:  Tumour Biol       Date:  2014-04-29

8.  Radiofrequency ablation versus surgical resection for hepatocellular carcinoma in Childs A cirrhotics-a retrospective study of 1,061 cases.

Authors:  Jiwei Huang; Roberto Hernandez-Alejandro; Kristopher P Croome; Lvnan Yan; Hong Wu; Zheyu Chen; Pankaj Prasoon; Yong Zeng
Journal:  J Gastrointest Surg       Date:  2010-10-30       Impact factor: 3.452

9.  Resection vs thermal ablation of small hepatocellular carcinoma: What's the first choice?

Authors:  Paola Tombesi; Francesca Di Vece; Sergio Sartori
Journal:  World J Radiol       Date:  2013-01-28

10.  Magnetic resonance imaging with gadoxetic acid for local tumour progression after radiofrequency ablation in patients with hepatocellular carcinoma.

Authors:  Tae Wook Kang; Hyunchul Rhim; Jisun Lee; Kyoung Doo Song; Min Woo Lee; Young-Sun Kim; Hyo Keun Lim; Kyung Mi Jang; Seong Hyun Kim; Geum-Youn Gwak; Sin-Ho Jung
Journal:  Eur Radiol       Date:  2016-01-08       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.